Sanofi-aventis 1Q 1Q Revenues: $9.4 billion (+3%) 1Q Earnings: $2.9 billion (flat) Comments: Pharmaceutical sales were $8.6 billion (-1%). Lovenox sales were $1.0 billion (+1%). Lantus sales were $993.0 million (+27%). Plavix sales were $910.6 million (+4%). Taxotere sales were $709.8 million (+8%). Eloxatin sales were $457.3 million (-7%) with European sales impacted by generic competition. Aprovel sales were up 11% to $417.4 million. Apidra sales were up 43% to $41.2 million. Vaccine ...